• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Model Number M00553550
Device Problems Premature Activation (1484); Use of Device Problem (1670); Device-Device Incompatibility (2919)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/07/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The device has been received for analysis; however, the evaluation has not yet been completed.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation that a hot axios stent was to be implanted transgastric to the duodenum to treat gastric obstruction to the duodenum during a gastrointestinal connection procedure performed on (b)(6), 2019.According to the complainant, as the physician was withdrawing the guidewire through the axios delivery system, the guidewire got stuck and could not be moved.The device was removed from the patient with the stent fully covered by the outer sheath.After the device was removed from the patient, the physician attempted to remove the guidewire from the axios delivery system, and the stent prematurely deployed off the delivery system.The procedure was not completed because another hot axios stent was not available.On (b)(6) 2019, another hot axios was successfully implanted.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: the hot axios stent was being implanted transgastric to the duodenum to treat gastric obstruction to the duodenum; however the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst or the biliary tract.
 
Manufacturer Narrative
Device code 1484 captures the reportable event of stent premature deployment.A hot axios stent and delivery system was returned for analysis.A visual examination of the device noted that the stent was received fully deployed and expanded.A guidewire was stuck inside the axios delivery system and could not be removed.The guidewire was peeled, and the corewire was exposed.The axios stent deployment hub was in its original position, the catheter hub was moved proximally, and the catheter lock was in the locked position.The yellow safety clip was returned.A functional evaluation was performed, and the catheter hub advanced and retracted without resistance.The stent deployment hub was also able to be moved without resistance.The stent was measured to be within specifications.There were no other issues noted.The reported deployment issues indicate operational difficulties experienced during the procedure and are likely due to anatomical or procedural factors.Procedural factors, such as the handling of the device and normal procedural difficulties encountered during the procedure, could have possibly affected the device performance and its integrity contributing to the reported event.Therefore, a review and analysis of all available information indicated that the most probable root cause is adverse event related to procedure.A review of the device history record (dhr) confirmed that the device met all material, assembly, and product specifications.A labeling review was performed, and there was evidence that the device was used in a manner inconsistent with the labeling.The hot axios stent was being implanted transgastric to the duodenum to treat gastric obstruction to the duodenum; however, the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst or the biliary tract.
 
Event Description
It was reported to boston scientific corporation that a hot axios stent was to be implanted transgastric to the duodenum to treat gastric obstruction to the duodenum during a gastrointestinal connection procedure performed on (b)(6) 2019.According to the complainant, as the physician was withdrawing the guidewire through the axios delivery system, the guidewire got stuck and could not be moved.The device was removed from the patient with the stent fully covered by the outer sheath.After the device was removed from the patient, the physician attempted to remove the guidewire from the axios delivery system, and the stent prematurely deployed off the delivery system.The procedure was not completed because another hot axios stent was not available.On (b)(6) 2019, another hot axios was successfully implanted.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: the hot axios stent was being implanted transgastric to the duodenum to treat gastric obstruction to the duodenum; however the hot axios stent and delivery system is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst or the biliary tract.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS STENT AND DELIVERY SYSTEM
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key9269066
MDR Text Key182374265
Report Number3005099803-2019-05259
Device Sequence Number1
Product Code PCU
Combination Product (y/n)N
PMA/PMN Number
K150692
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/01/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/15/2021
Device Model NumberM00553550
Device Catalogue Number5355
Device Lot Number0023651046
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/28/2019
Date Manufacturer Received12/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age57 YR
-
-